Stock Taper
SCREENER COMPARE ANY 2 STOCKS
DMIIU
DRUGS MADE IN AMERICA ACQUISITION II CORP. UNIT
NASDAQ
$10.25
▲ UP 0.49% (0.05)

KEY STATISTICS

Market Cap$712.83 M
52w High$10.80
52w Low$9.94
Dividend Yield—
Frequency—
P/E—
Volume2
Shares Out.69.54M

COMPANY

LEADERSHIP

Roger Bendelac
CHIEF EXECUTIVE
Roger Bendelac

ABOUT

SECTOR
Financial Services
WENT PUBLIC
September 25, 2025
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
2

PRICE

$10.25 ▲ UP 0.49% (+$0.05)
$9.90$10.20$10.5011:13 AM11:13 AM11:13 AM11:13 AM11:13 AM11:13 AM11:14 AM10.25

About Drugs Made In America Acquisition II Corp. Unit

https://dmaacorp.com/ ↗

A Cayman Islands SPAC targeting pharmaceutical/drug sector acquisitions to reduce U.S. reliance on global manufacturing, with units comprising one share and a right for one-tenth of a share upon a successful business combination.

INDUSTRY

Shell Companies

A SERVICE DRUGS MADE IN AMERICA ACQUISITION II CORP. UNIT IS KNOWN FOR

Special Purpose Acquisition Company (SPAC) Unit

Drugs Made In America Acquisition II Corp. is a SPAC that raises capital through an IPO to acquire or merge with a private company, aiming to take it public, without currently offering products or services.

COMPETITORS

COMPETITOR
ASPCU COMPARE
ATII COMPARE
BSAA COMPARE
ONCHU COMPARE

SECTORS PEERS

PEERPRICE
GAM$67.16COMPARE
GAIN$16.43COMPARE
NCDL$12.31COMPARE
MSIF$12.65COMPARE
NEWT$11.91COMPARE
EIC$10.03COMPARE
OCCI$2.71COMPARE